Butoconazole Nitrate

CHEMBL1200398 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
474.8 g/mol
LogP
Phase
4

The nitrate salt form of butoconazole, used as a topical vaginal antifungal for the treatment of vulvovaginal candidiasis. It inhibits fungal ergosterol biosynthesis, compromising the integrity of the fungal cell membrane. A bioadhesive formulation allows for a single-dose treatment regimen.

Peso Molecular

474,8000 g/mol

TPSA

109,00 Ų

Mecanismo de Ação

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1.O=[N+]([O-])O

InChI

InChI=1S/C19H17Cl3N2S.HNO3/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22;2-1(3)4/h1-5,7-8,10-11,13,16H,6,9,12H2;(H,2,3,4)

Molecular Formula

C19H18Cl3N3O3S

HBD / HBA

1 / 5

Ligações Rotacionáveis

7

Átomos Pesados

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

The nitrate salt form of butoconazole, used as a topical vaginal antifungal for the treatment of vulvovaginal candidiasis. It inhibits fungal ergosterol biosynthesis, compromising the integrity of the fungal cell membrane. A bioadhesive formulation allows for a single-dose treatment regimen.

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Yes, Butoconazole Nitrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200398. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 47471. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.